Soligenix, Inc. (SNGX) Social Stream
SOLIGENIX INC (SNGX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering SOLIGENIX INC.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued March 31, 2022
The Trend in the Analyst Price Target
SNGX's average price target has moved down $0.06 over the prior 16 months.
Over the past 52 days, SNGX's average upside potential has been 511.01%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
SNGX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
SNGX's average broker recommendation rating improved by 0 over the prior 153 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SNGX as an investment opportunity.
- In the context of all US stocks, SOLIGENIX INC's number of analysts covering the stock is higher than practically none of them.
- To contextualize these metrics, consider that out of all US stocks, SOLIGENIX INC's variance in analysts' estimates is lower than nearly 100% of them.
- In terms of how SOLIGENIX INC fares relative to Healthcare stocks, note that its average analyst price target is greater than 14.25% of that group.
- In the context of Healthcare stocks, SOLIGENIX INC's upside potential (average analyst target price relative to current price) is greater than 164.19% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to SOLIGENIX INC are LTRN, ADTX, and MDNA.
View All Top Stocks by Price Target
Make investment decisions regarding SNGX using the data that counts. Try POWR Ratings for free.